This post was originally published on this site Elenbecestat and BAN2401, two potential anti-amyloid therapies, were selected by the Alzheimer’s Clinical Trials Consortium (ACTC) to be evaluated in clinical studies aiming to prevent progression to early stages of Alzheimer’s disease. ACTC is a network of 35 primary clinical trial sites across the U.S., established by the…
This post was originally published on this site High blood levels of primary fatty acid amides (PFAMS), a class of fatty molecules involved in sleep and movement control, are associated with increased accumulation of beta-amyloid protein in the cerebrospinal fluid of patients with Alzheimer’s disease, a study finds. Researchers believe that this class of fatty…
This post was originally published on this site A new program called the Dementia Friendly Hospital Initiative is set to be launched in North Carolina to raise awareness among healthcare providers on how patients with Alzheimer’s disease and dementia experience care interventions and how to meet their needs. Led by the University of North Carolina…
This post was originally published on this site I recently discovered this article celebrating Mother’s Day and found it to be an enjoyable read because it rings true for me. Honest Abe earned his nickname All of us tend to be sentimental about our moms. Inspired by wonderful mothers, many of us could write 100…
This post was originally published on this site An online program that teaches how to focus on positive emotions can help caregivers of family members with dementia to cope better with stress, and reduce their depression and anxiety symptoms, results from a clinical study suggest. The six-week skill-building intervention, called Life Enhancing Activities for Family…
This post was originally published on this site Tetra Discovery Partners is launching a Phase 2 clinical trial for BPN14770 — found to improve working memory in older patients in earlier trials — as a treatment for people with early stage Alzheimer’s disease. The trial, called PICASSO AD (NCT03817684), is recruiting in about 60 clinical…
This post was originally published on this site Adding memantine to a cholinesterase inhibitor can significantly ease certain neuropsychiatric symptoms, including psychosis and troubling motor or nighttime behavior, in people with moderate-to-severe Alzheimer’s disease, according to pooled data from three Phase 3 clinical trials. But it was not seen to be of any benefit in…
This post was originally published on this site Caregivers are often isolated. This may be particularly true of those who provide care for loved ones in the late stages of Alzheimer’s disease. As it progresses, patients are less likely to get out and about. Every day they lose a little bit of their freedom, and…
This post was originally published on this site Cumbersome security procedures, rising airfares, and shrinking legroom have made commercial air travel difficult enough these days — even for healthy passengers. Imagine how much harder it is for patients with rare diseases who must get to doctors’ appointments or clinical trials that are hundreds of miles…
This post was originally published on this site Long-term use of thiazide diuretics — a hypertension medication — may lower the risk of bone fractures, particularly hip fractures, in people with Alzheimer’s, a disease with a high risk of fractures due to falls, a Finnish study suggests. The study, “Long-term thiazide use and risk of…
